Some spin · most spun: City AM 48/100 See every outlet’s spin ↓Photo as used by Yorkshire Post for “Applied Nutrition: Health and wellness brand backed by Coleen Rooney sees profits jump”How Yorkshire Post framed it: Yorkshire Post uses a photograph of the London Stock Exchange Group interior and display screens. It gives the story a financial-market setting rather than illustrating the products or Coleen Rooney.
Applied Nutrition's unaudited preliminary results show revenue of £161.6 million and pre-tax profit of £41 million for the year ended 31 July 2026. Revenue rose 50.9% and pre-tax profit rose 43.9%. Free cash flow fell, and the company paid no dividend during the year.
How the coverage differs
All four headlines or summaries focus on profit growth; Belfast Telegraph, The Independent and City AM also put weight-loss jabs in their headlines. Of the two full articles, The Independent reports that market expectations remained unchanged and discusses higher whey costs, while City AM stresses the company's London listing and high-profile backers. Neither full article mentions the fall in free cash flow or the absence of a dividend; the limited material supplied for Yorkshire Post and Belfast Telegraph does not establish whether their full coverage included those facts.
Applied Nutrition reported a 43.9% rise in annual pre-tax profit to £41 million as revenue increased 50.9% to £161.6 million. The figures cover the year ended 31 July 2026 and come from unaudited preliminary results published on Monday. The Liverpool-based supplements business kept its expectations for the following financial year unchanged.R1R3S3
The company launched a range aimed at people using GLP-1 weight-loss medication during the year. Chief executive Thomas Ryder says new products are bringing in customers beyond its traditional sports nutrition audience. The group also says its partnership with Coleen Rooney has broadened its appeal.S3
Why it matters
The figures need care because coverage uses different profit measures. City AM describes £40.6 million as pre-tax profit and says profit nearly doubled. The company's results identify £40.6 million as operating profit, up 44.5%, and £41 million as pre-tax profit, up 43.9%. Neither of those measures nearly doubled.R1S4
Profit growth also did not translate into higher free cash flow. The company's measure fell 35.8%, from £16.5 million to £10.6 million. It paid no dividend during the year, compared with £14.7 million a year earlier, and says it does not expect another before its 2028 financial year.R2
Management says it is keeping cash for additional capacity, efficiency improvements and possible acquisitions. It also says its newly acquired US business needed recapitalisation. The company expects further working capital needs from that business and higher whey purchasing costs, tying up more cash in day-to-day operations.R2
The background
Applied Nutrition mainly sells through other businesses, including retailers, grocers, gyms and sports clubs. Its customers range from professional athletes to people seeking to build muscle or lose weight. The Independent reports that its products are sold in more than 80 countries and that it also sells online.S3
The group says sales of Critical Whey increased 142% following a relaunch. That growth has made whey-based products a larger part of its sales. It expects the average cost of whey to be higher this financial year than last year, despite a recent easing in raw material prices, and says customer price increases partly offset the pressure.S3R3
What happens next
The board continues to expect approximately £205 million in revenue and £49 million in adjusted earnings before interest, tax, depreciation and amortisation for 2026-27. It expects that earnings margin to fall slightly, reflecting whey costs and a greater contribution from lower-margin US sales. These are forecasts rather than results already achieved.R3
The company's calendar lists its annual general meeting for 14 January 2027. Its next half-year ends on 31 January, with interim results scheduled for March.R4
What most outlets left out
Material facts only a few of the outlets we read included.
Free cash flow fell 35.8% despite higher revenue and profit.R2
Cash generation moved differently from the headline earnings figures.
No dividend was paid during the year, and the company does not expect another before its 2028 financial year.R2
The company says it is retaining cash for investment and working capital.
Fact check: every point labelled
What is confirmed, what is only reported, and what is claim or speculation. Every point links to its source.
What we know
On the record or independently reported by more than one outlet.
confirmedUnaudited preliminary results published on 16 November cover the year ended 31 July 2026: revenue rose 50.9% to £161.6 million; pre-tax profit rose 43.9% to £41 million.R1
confirmedThe company kept its current market expectations unchanged.R3
confirmedThe company's free cash flow measure fell 35.8% to £10.6 million from £16.5 million.R2
confirmedNo dividend was paid during the year, compared with £14.7 million the previous year.R2
confirmedThe company calendar schedules the AGM for 14 January 2027, the half-year end for 31 January and interim results for March.R4
Reported but not yet confirmed
Reported as fact, but from a single origin.
reportedThe Independent: Applied Nutrition launched a range aimed at consumers using GLP-1 weight-loss medication.S3
reportedThe Independent: The Liverpool-based business mainly sells through retailers, grocers, gyms and sports clubs, serves athletes and consumers seeking weight loss or muscle gain, sells in more than 80 countries and also sells online.S3
Claims and disputes
What people say. Not established fact.
claimedThomas Ryder: New products are attracting customers beyond the traditional sports nutrition audience.S3
claimedApplied Nutrition: The partnership with Coleen Rooney has broadened the brand's appeal.S3
disputedCity AM; contradicted by Applied Nutrition's preliminary results: City AM's description of £40.6 million as pre-tax profit and profit as nearly doubled conflicts with the filing: £40.6 million is operating profit, up 44.5%, while pre-tax profit rose 43.9% to £41 million.S4R1
claimedApplied Nutrition: No further dividend is anticipated before the 2028 financial year.R2
claimedApplied Nutrition: Cash is being retained for capacity, efficiency and possible acquisitions, while the acquired US business needed recapitalisation.R2
claimedApplied Nutrition: The acquired US business and higher whey purchasing costs are expected to increase working capital needs.R2
claimedApplied Nutrition: Critical Whey sales rose 142% after its relaunch, increasing the contribution from whey-based products.S3
claimedApplied Nutrition: Average whey costs are expected to be higher in 2026-27 despite recent raw material price declines; higher customer prices partly offset the impact.R3
claimedApplied Nutrition: The company expects approximately £205 million revenue and £49 million adjusted EBITDA for 2026-27, with a slightly lower EBITDA margin because of whey costs and lower-margin US sales.R3
Still unknown
Whether average whey costs and price increases will develop as management expects.
Key questions
How much profit did Applied Nutrition make?
Its unaudited results show £41 million in pre-tax profit, up 43.9%. Operating profit was £40.6 million, a different measure.R1
Did its profit nearly double?
The filing reports pre-tax profit growth of 43.9% and operating profit growth of 44.5%. Neither supports that description in City AM's report.R1S4
Why has it kept its forecasts unchanged?
The board cites the early stage of the new financial year. It also expects whey costs and a larger contribution from lower-margin US sales to reduce its adjusted earnings margin slightly.R3
Is it paying a dividend?
It paid none during the year and does not expect another before its 2028 financial year. That is its current expectation, not a guaranteed payment date.R2
Spin meter
How each outlet framed this story, scored on the wording and choices in that article, not on the outlet’s reputation.
Headlines compared: Yorkshire Post highlights Coleen Rooney's backing alongside rising profits. Belfast Telegraph and The Independent use the same headline about cashing in on weight-loss jabs, while City AM presents the jabs as a driver of demand.
City AMFraming: Not political · Spin 48/100 · Headline matches story: partly
“Applied Nutrition profit surges as weight-loss jabs fuel demand”
Straight reportingHeavy spin
City AM frames Applied Nutrition as a weight-loss market and London listing success, while noting whey cost pressures.
Why? 4 framing techniques
emphasisnearly doubled its profit This overstates the established 43.9% pre-tax profit increase, although the article later gives a figure of 44%.
emphasisweight-loss jabs fuel demand The headline stresses a link to weight-loss medication without quantifying the new range's contribution to the results.
omission The report does not mention unchanged market expectations, the fall in free cash flow or the absence of a dividend.
selective quotegoing from strength to strength The positive analyst assessment reinforces the growth narrative without a corresponding outside assessment of financial risks.
The IndependentFraming: Not political · Spin 25/100 · Headline matches story: yes
“Applied Nutrition profits jump as it cashes in on weight-loss jab market”
Straight reportingHeavy spin
The Independent leads on profit growth and weight-loss products while also highlighting whey costs and unchanged market expectations.
Why? 2 framing techniques
emphasisto cash in on the rising popularity of weight-loss medication The article foregrounds the new range as a commercial opportunity, although it does not quantify its contribution to profits.
omission The report does not mention the fall in free cash flow or that no dividend was paid, although it covers higher whey costs and unchanged expectations.
Yorkshire PostFraming: Not political · Spin 12/100 · Headline matches story: yes
“Applied Nutrition: Health and wellness brand backed by Coleen Rooney sees profits jump”
Straight reportingHeavy spin
Yorkshire Post frames the profit increase around celebrity backing and demand linked to weight-loss medication.
Why? 1 framing technique
emphasisbacked by Coleen Rooney The headline foregrounds a celebrity backer rather than the financial details of the profit increase.
Belfast TelegraphFraming: Not political · Spin 10/100 · Headline matches story: unknown
“Applied Nutrition profits jump as it cashes in on weight-loss jab market”
Straight reportingHeavy spin
Belfast Telegraph's headline emphasises profits and the commercial opportunity presented by weight-loss medication.
Why? 1 framing technique
loaded languagecashes in The phrase gives the company's response to demand a more opportunistic tone.
Earlier coverage of similar events
How outlets reported related stories before this one. Compare for yourself.
This story was written and checked by AI agents using only the sources above, then published automatically. Facts are labelled by how well they are supported. If something is wrong, tell us: we check every report against the sources and publish corrections. Editorial policy